Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS)

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 11, 2000, Pages 972-982

  Wong, Nelson K Y ^a,b   He, Bei Ping ^b   Strong, Michael J ^a,b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Amyotrophic lateral sclerosis; Motor neuron disease; Neurofilament; Peripherin; internexin; actin

Indexed keywords

ALPHA INTERNEXIN; ALPHA TUBULIN; ANTIBODY; BETA ACTIN; MESSENGER RNA; NESTIN; PERIPHERIN; PROTEIN SUBUNIT; SULFUR 35; UBIQUITIN; VIMENTIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL AGGREGATION; CERVICAL SPINE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERMEDIATE FILAMENT; MALE; NERVE FIBER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA PROBE; SPHEROID CELL; SPINAL CORD MOTONEURON; STOICHIOMETRY; TISSUE SECTION;

EID: 0033763630     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.11.972     Document Type: Article

References (85)

1. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis
2. Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis
3. Unusual particles in motor neuron disease
4. Proximal axonal enlargement in motor neuron disease
5. Motor neuron inclusions in ALS are heavily ubiquitinated
6. Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: An immunohistochemical study
7. Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease
8. Cytoskeletal abnormalities in motor neuron disease. An immunohistochemical study
9. Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases
10. Peripherin immunoreactive structures in amyotrophic lateral sclerosis
11. Immunocytochemical study of primary motor area in motor neuron disease
12. Neurofilament metabolism in sporadic amyotrophic lateral sclerosis
13. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis
14. Mice overexpressing the human neurofilament heavy gene as a model of ALS
15. Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons
16. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease
17. Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein
18. A mutant neurofilament subunit causes massive, selective motor neuron death: Implications for the pathogenesis of human motor neuron disease
19. Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport
20. Enhanced ex vivo cose-dimentation of high molecular weight neurofilament protein (NFH) with microtubules following in vivo aluminum chloride exposure. Inhibition of dephosphorylation-dependant dissociation
21. Spinal motor neuroaxonal spheroids in chronic aluminum neurotoxicity contain phosphatase-resistant high molecular weight neurofilament (NFH)
22. Expression of neurofilament subunits in neurons of the central and peripheral nervous system: An immunohistochemical study with monoclonal antibodies
23. Molecular and cellular biology of intermediate filaments
24. Related amino acid sequences in neurofilaments and non-neuronal intermediate filaments
25. Neurofilament protein heterodimers as assembly intermediates
26. Neurofilaments are obligate heteropolymers in vivo
27. Characterization of interactions between the neurofilament triplet proteins by the yeast two-hybrid system
28. Neurofilament gene expression: A major determinant of axonal caliber
29. Associations between intermediate filament proteins expressed in cultured dorsal root ganglion neurons
30. Localization of vimentin, the nonspecific intermediate filament protein, in embryonal glia and in early differentiating neurons. In vivo and in vitro immunofluorescence study of the rat embryo with vimentin and neurofilament antisera
31. Initial expression of neurofilaments and vimentin in the central and peripheral nervous system of the mouse embryo in vivo
32. The predicted amino acid sequence of α-internexin is that of a novel neuronal intermediate filament protein
33. α-Internexin, a novel neuronal intermediate filament protein, precedes the low molecular weight neurofilament protein (NF-L) in the developing rat brain
34. Developmental patterns of intermediate filament gene expression in the normal hamster brain
35. Dynamics of neuronal intermediate filaments: A developmental perspective
36. Simultaneous up-regulation of neurofilament proteins during the postnatal development of the rat nervous system
37. Differential expression of neurofilament triplet proteins during brain development
38. Ontogeny of the neuronal intermediate filament protein, peripherin, in the mouse embryo
39. Differential expression of two neuronal intermediate filament proteins, peripherin and the low-molecular-mass neurofilament protein (NF-L), during the development of the rat
40. Differential regulation of peripherin and neurofilament gene expression in regenerating rat DRG neurons
41. Distribution of a novel 57 kDa intermediate filament (IF) protein in the nervous system
42. Heterodimeric associations between neuronal intermediate filament proteins
43. Transfected rat high-molecular weight neurofilament (NF-H) coassembles with vimentin in a predominantly nonphosphorylated form
44. Expression of rat neurofilament proteins NF-L and NF-M in transfected non-neuronal cells
45. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments
46. Peripherin assembles into homopolymers in SW13 cells
47. Expression of NF-L and NF-M in fibroblasts reveals coassembly of neurofilament and vimentin subunits
48. Some neural intermediate filaments contain both peripherin and the neurofilament proteins
49. Neuronal intermediate filament protein α-internexin facilitates axonal neurite elongation in neuroblastoma cells
50. Expression of the neurofilament protein NF-H in L cells
51. Developmentally regulated stabilization of neuronal intermediate filaments in rat cerebral cortex
52. Late-onset death of motor neurons in mice overexpressing wild-type peripherin
53. Overexpression of α-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice
54. Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons
55. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis
56. Rapid induction of the major embryonic α-tubulin mRNA, Tα1, during nerve regeneration in adult rats
57. Nitric oxide synthase expression in cervical motor neurons of sporadic amyotrophic lateral sclerosis
58. Ubiquitin deposits in anterior horn cells of motor neuron disease
59. mRNA levels of all three neurofilament proteins decline following nerve transection
60. Dynamic changes in motoneurons during regeneration
61. Axonal regrowth upregulates β-actin and jun D mRNA expression
62. Inhibition of transducin activation and guanosine triphosphate activity by aluminum ion
63. Changes in the cytoskeletal proteins in the rat facial nucleus following axotomy
64. Response of facial and rubrospinal neurons to axotomy: Changes in mRNA expression for cytoskeletal proteins and GAP-43
65. Reductions in motoneuronal neurofilament synthesis by successive axotomies: A possible explanation for the conditioning lesion effect on axon regeneration
66. Regulation of peripherin and neurofilament expression in regenerating rat motor neurons
67. Axotomy-induced changes in the expression of a type III neuronal intermediate filament gene
68. Corticospinal neurons exhibit a novel pattern of cytoskeletal gene expression after injury
69. Transcriptional and post-transcriptional mechanisms regulating neurofilament and tubulin gene expression during normal development of the rat brain
70. Characterization of the mouse neurofilament light (NF-L) gene promoter by in vitro transcription
71. Okadaic acid suppresses neural differentiation-dependent expression of the neurofilament-L gene in P19 embryonal carcinoma cells by post-transcriptional modification
72. Multiple neuron-specific enhancers in the gene coding for the human neurofilament light chain
73. The first intron of the mouse neurofilament light gene (NF-L) increases gene expression
74. Cytopathology of amyotrophic lateral sclerosis
75. The ubiquitin-mediated proteolytic pathway
76. Cytoskeletal abnormalities in motor neuron disease
77. Antibody to an abnormal protein in amyotrophic lateral sclerosis identifies Lewy body-like inclusion in ALS and Lewy bodies in Parkinson's disease
78. An essential cytoskeletal linker protein connecting actin microfilaments to intermediate filaments
79. The intermediate filament protein peripherin in the specific interaction partner of mouse BPAG1-n (dystonin) in neurons
80. Stable interaction between G-actin and neurofilament light subunit in dopaminergic neurons
81. Mechanical effects of neurofilament cross-bridges. Modulation by phosphorylation, lipids, and interactions with F-actin
82. The mouse dystonia musculorum gene is a neural isoform of bullous pemphigold antigen 1
83. Integrators of the cytoskeleton that stabilize microtubules
84. Nitration of the low molecular weight neurofilament (NFL) is equivalent in sporadic amyotrophic lateral sclerosis and control cervical spinal cord
85. Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L